X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1387) 1387
ezh2 (1232) 1232
humans (1133) 1133
cancer (631) 631
oncology (602) 602
animals (561) 561
methylation (520) 520
expression (428) 428
epigenetics (423) 423
cell biology (418) 418
cell line, tumor (415) 415
gene expression (401) 401
dna methylation (395) 395
enhancer of zeste homolog 2 protein (393) 393
mice (353) 353
female (344) 344
biochemistry & molecular biology (338) 338
macromolecular substances (332) 332
male (317) 317
group protein ezh2 (306) 306
histones - metabolism (295) 295
research (268) 268
polycomb repressive complex 2 - metabolism (264) 264
genetic aspects (263) 263
gene expression regulation, neoplastic (259) 259
proteins (258) 258
chromatin (255) 255
metastasis (244) 244
epigenesis, genetic (241) 241
proliferation (232) 232
apoptosis (226) 226
article (222) 222
genes (220) 220
polycomb repressive complex 2 - genetics (219) 219
cell proliferation (216) 216
epigenetic inheritance (214) 214
analysis (211) 211
polycomb (210) 210
tumors (210) 210
gene-expression (206) 206
mutation (202) 202
stem cells (198) 198
development and progression (197) 197
prostate-cancer (194) 194
prognosis (184) 184
enhancer of zeste homolog 2 protein - metabolism (178) 178
enhancer of zeste homolog 2 protein - genetics (172) 172
differentiation (171) 171
breast-cancer (170) 170
cells (170) 170
stem-cells (164) 164
health aspects (162) 162
histones (159) 159
micrornas - genetics (158) 158
polycomb repressive complex 2 (155) 155
lysine (153) 153
middle aged (151) 151
histone methyltransferase (150) 150
care and treatment (143) 143
hematology (142) 142
gene silencing (140) 140
progression (139) 139
polycomb group proteins (138) 138
cell cycle (136) 136
somatic mutations (135) 135
genetics & heredity (132) 132
gene (131) 131
histone methyltransferase ezh2 (128) 128
inhibition (128) 128
down-regulation (125) 125
methyltransferases (125) 125
histone h3 (124) 124
carcinoma (122) 122
medicine, research & experimental (122) 122
signal transduction (120) 120
breast cancer (119) 119
aged (114) 114
microrna (114) 114
multidisciplinary sciences (114) 114
prc2 (113) 113
prostate cancer (113) 113
adult (112) 112
growth (111) 111
transcription (108) 108
acute myeloid-leukemia (107) 107
methyltransferase gene ezh2 (107) 107
neoplasms - genetics (106) 106
physiological aspects (106) 106
cell growth (105) 105
biology (104) 104
immunohistochemistry (104) 104
mutations (104) 104
rna interference (104) 104
micrornas (102) 102
pharmacology & pharmacy (101) 101
tumorigenesis (101) 101
polycomb repressive complex 2 - antagonists & inhibitors (100) 100
promoter regions, genetic (98) 98
kinases (97) 97
deoxyribonucleic acid--dna (96) 96
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Science, ISSN 1347-9032, 10/2017, Volume 108, Issue 10, pp. 2069 - 2078
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 13, pp. 2733 - 2743
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 2012, Volume 8, Issue 11, pp. 890 - 896
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 04/2017, Volume 13, Issue 4, pp. 389 - 395
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 06/2015, Volume 11, Issue 6, pp. 432 - 437
Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 01/2018, Volume 45, Issue 1, pp. 58 - 67
Epigallocatechin‐3‐gallate ( EGCG ) is a type of catechin. It exhibits excellent antioxidant effects and anti‐tumour activities for cancer chemoprevention. The... 
EZH | colorectal cancer | cell cycle | EGCG | EZH2 | APOPTOSIS | PHYSIOLOGY | PHARMACOLOGY & PHARMACY | CYCLE CHECKPOINTS | COMBINATION | EXPRESSION | Prevention | Catechin | Analysis | Colorectal cancer | Cancer | Cell proliferation | Genes | Colorectal carcinoma | Epigallocatechin-3-gallate | Encyclopedias | Homology | Genomes | Tissues | Antioxidants | Chemotherapy | Inhibitors | Lysine | Cell lines | Cell cycle | Synergistic effect | Bioinformatics | Cell migration | Histone H3 | Tumors | G1 phase | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 04/2015, Volume 520, Issue 7546, pp. 239 - 242
Non-small-cell lung cancer is the leading cause of cancer-related death worldwide(1). Chemotherapies such as the topoisomerase II (TopoII) inhibitor etoposide... 
SURVIVAL | ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | COMPLEXES | SWI/SNF | GENE-EXPRESSION PROFILES | MUTATIONS | DRUG-COMBINATION | POLYCOMB | MICROARRAY DATA | CANCER CELL-LINES | Polycomb Repressive Complex 2 - antagonists & inhibitors | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Humans | Lung Neoplasms - pathology | Molecular Targeted Therapy | Antineoplastic Agents, Phytogenic - therapeutic use | Nuclear Proteins - genetics | DNA Helicases - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Genes, erbB-1 - genetics | Etoposide - pharmacology | Etoposide - therapeutic use | Topoisomerase II Inhibitors - pharmacology | Transcription Factors - genetics | Anaphase - drug effects | Enhancer of Zeste Homolog 2 Protein | Topoisomerase II Inhibitors - therapeutic use | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Protein research | Care and treatment | Oncology, Experimental | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Gene expression | Cancer | Proteins | Genes | Lung cancer | Genetic engineering | Mutation | Kinases | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Apoptosis | Index Medicus | Etoposide | Chemotherapy | EZH2 inhibition | BRG1 | EGFR
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 04/2017, Volume 13, Issue 4, pp. 381 - 388
Journal Article
Nature communications, ISSN 2041-1723, 04/2016, Volume 7, Issue 1, pp. 11384 - 11384
Journal Article